Related Experiment Videos
Evidence-based medicine in migraine prevention
Min-Suk Yoon1, Irini Savidou, Hans-Christoph Diener
1University Hospital Essen, Department of Neurology, Hufelandstrasse 55, 45122 Essen, Germany.
Expert Review of Neurotherapeutics
|June 9, 2005
Summary
Migraine prevention has advanced with neuromodulators like topiramate and valproic acid proving effective. Large clinical trials are establishing new standards for evidence-based migraine prevention strategies.
Area of Science:
- Neurology
- Pharmacology
Background:
- Migraine is a disabling neurological condition impacting daily life.
- Acute migraine treatments like triptans offer rapid relief.
- Migraine prevention has lagged due to challenges in drug development.
Purpose of the Study:
- To review current migraine prevention strategies.
- To highlight advancements in clinical trial design for migraine prevention.
- To discuss novel preventive treatments, including topiramate.
Main Methods:
- Review of recent clinical trial data.
- Analysis of evidence-based medicine in migraine prevention.
- Focus on neuromodulators as preventive agents.
Main Results:
- Neuromodulators (valproic acid, topiramate) demonstrate efficacy in large clinical trials.
- Clinical trial programs are setting new standards for migraine prevention.
- Topiramate is identified as a key new development.
Conclusions:
- Significant progress in migraine prevention is evident.
- Evidence-based approaches and novel drugs like topiramate are transforming migraine management.
- Future research and trials will continue to refine preventive therapies.